Immunovant, Inc. (IMVT) Misses Q1 EPS by 1c

Immunovant, Inc. (NASDAQ: IMVT) reported Q1 EPS of ($0.71), $0.01 worse than the analyst estimate of ($0.70).

For earnings history and earnings-related data on Immunovant, Inc. (IMVT) click here.

You May Also Be Interested In

• Citi upgrades O-I Glass to Buy with $9 price target, opens 90-Day upside catalyst watch
• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
• ScanSource (SCSC) Tops Q4 EPS by 32c